SUMOylation substrates in neuronal intranuclear inclusion disease (Q34484119)

2 August 2017

title

SUMOylation substrates in neuronal intranuclear inclusion disease (English)

1 reference

2 August 2017

1 reference

J Takahashi-Fujigasaki

1

1 reference

2 August 2017

K Arai

2

1 reference

2 August 2017

N Funata

3

1 reference

2 August 2017

H Fujigasaki

4

1 reference

2 August 2017

publication date

1 February 2006

1 reference

Neuropathology and Applied Neurobiology

2 August 2017

published in

1 reference

2 August 2017

volume

32

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

92-100

1 reference

Neuronal intranuclear hyaline inclusion disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Glutamine repeats and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

SUMO modification of Huntingtin and Huntington's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Nuclear and unclear functions of SUMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Intracellular localization of proteasomal degradation of a viral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Intracellular localization of proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

SUMO: a regulator of gene expression and genome integrity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Class II histone deacetylases: structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

The promyelocytic leukemia nuclear body: sites of activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Nucleocytoplasmic protein traffic and its significance to cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

The nuclear pore complex: nucleocytoplasmic transport and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2990.2005.00705.X

10.1111/J.1365-2990.2005.00705.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference